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Medication adherence early after stroke: using the Perceptions and 1 
Practicalities framework to explore stroke survivors’, informal carers’ and 2 
nurses’ experiences of barriers and solutions. 3 
Abstract  4 
Background: Secondary prevention medication after stroke reduces risk of 5 
recurrence, but adherence is often poor. Stroke survivors’, carers’ and nurses’ 6 
perspectives of early post-stroke medication adherence are unexplored. 7 
Aim: to explore stroke survivors’, carers’ and nurses’ views and experiences about 8 
adhering to medication early after post-stroke hospital discharge.  9 
Methods: Qualitative individual and group interviews, utilizing the Perceptions and 10 
Practicalities framework. Nine people <2 months post-stroke, three carers, and 11 
fifteen nurses from one UK stroke unit participated. Interviews were digitally 12 
recorded, transcribed and thematically analysed.  13 
Results: There were four main themes with two subthemes. 1) Perceptions of 14 
medication taking after stroke. Factors affecting adherence included depression, 15 
imperceptible benefits, and concerns about adverse effects. 2) Perceptions about 16 
those at higher risk of poor medication adherence.  Nurses suggested that poor 17 
adherence might be more likely in those living alone or with previous nonadherence. 18 
3) Practicalities of taking medication early after stroke; these included post-stroke 19 
disabilities, cognition, polypharmacy, and lack of information. 4a)  Practicalities of 20 
addressing poor medication adherence during the hospital stay. Solutions included 21 
multidisciplinary co-ordination, but nurses and stroke survivors described suboptimal 22 
use of opportunities to promote adherence. 4b) Practicalities of addressing poor 23 
medication adherence post-discharge. Solutions included modifications and support 24 
3 
 
from carers, but stroke survivors reported difficulties in evolving systems for taking 1 
medications.   2 
Conclusions: Stroke survivors and informal carers lack knowledge and support 3 
needed to manage medication early after discharge. Nurses’ opportunities to 4 
promote medication adherence are under-exploited. Medication adherence 5 
strategies to support stroke survivors early after discharge are needed. 6 
Keywords 7 
Caregivers; Medication Adherence; Patient Discharge; Polypharmacy; Secondary 8 
Prevention; Stroke. 9 
 10 
INTRODUCTION  11 
Recurrence after a first stroke is a common, yet often preventable, event. Although 12 
there is much heterogeneity in reporting, the 10-year cumulative risk of stroke 13 
recurrence in those who survive the initial event has been estimated at 39.2% (95% 14 
CI, 27.2-51.2) (Mohan et al., 2011). More than a quarter of these recurrent events 15 
occur within 12 months, with a cumulative risk of stroke recurrence of 11.1% (95% 16 
CI, 9.0-13.3) at 1 year post-stroke (Mohan et al., 2011), but medication substantially 17 
reduces this risk (Hackam and Spence, 2011). Current clinical guidelines 18 
recommend several secondary prevention medications which should be started 19 
immediately and continued indefinitely (Intercollegiate Stroke Working Party, 2016), 20 
but medication adherence is often poorly managed during stroke discharge planning 21 
(Andrew et al., 2017).  22 
 23 
Poor medication adherence is a global problem which contributes to poor health 24 
outcomes across long-term conditions (Yusuf, 2002); only half of prescribed 25 
4 
 
medications are actually taken (Sabate, 2003). Several factors are known to predict 1 
poor medication adherence after stroke, including lack of support with medications, 2 
polypharmacy, and severe stroke (Al-AlShaikh et al., 2016a); anger (Santos and 3 
Ferro, 2017) as measured using the State-Trait Anger Expression Inventory-2 4 
(Spielberger,1999); concerns about treatment (Al Alshaikh et al., 2016a; Crayton et 5 
al., 2017); and knowledge and beliefs about medication (Crayton et al., 2017). The 6 
contributions of informal carers are also increasingly recognised, but there is a lack 7 
of evidence on factors affecting medication adherence in people who rely such 8 
support (De Simoni, Mant and Sutton, 2015).  9 
 10 
The development of effective interventions to improve medication adherence is 11 
important (Nunes et al., 2009) but challenging (Nieuwlaat et al., 2014), and many 12 
studies in stroke are not based on a comprehensive understanding of stroke 13 
survivors’ needs (Bridgwood et al., 2018; Al AlShaikh et al., 2016b). In order to 14 
ascertain the barriers which may affect medication adherence early after stroke, and 15 
to develop interventions to overcome them, it is important to understand the 16 
perceptions of stroke survivors, informal carers, and health professionals. A recent 17 
meta-synthesis of twelve qualitative studies, has been conducted on stroke 18 
survivors’, carers’ and health professionals’ perspectives of medication taking after 19 
stroke (Gibson et al., 2020). Of the 412 participants across the included studies, 20 
most were stroke/TIA survivors with only 8% being health professionals.  21 
The meta-synthesis identified a substantial burden of 'medicines work' . This work 22 
consists of information work, health care work, carer work, emotional work 23 
and practical work, whose performance necessitates mutual trust, and trust in the 24 
benefits of medicines themselves, to overcome barriers to medication adherence 25 
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and persistence. However, none of the studies identified in this meta-synthesis 1 
focused on the period immediately after hospital discharge; instead, they mainly 2 
examined long-term medication adherence.. Many of the studies in this review also 3 
had significant methodological weaknesses, with nine of moderate and three of poor 4 
quality. In particular, few studies have utilised any specific theoretical framework to 5 
guide either data collection or analysis. An exception is Jamison et al (2017) who 6 
utilised the Perceptions and Practicalities (PaPa) model (Harding and Horne, 2001). 7 
This model enables exploration of perceptual factors or beliefs about medicines, 8 
which may contribute to intentional non-adherence, and practical or resource factors 9 
which contribute to non-intentional non-adherence. The PaPa model is a particularly 10 
suitable model to underpin studies of medication adherence as it has the express 11 
purpose of supporting identification and classification of factors influencing 12 
medication adherence, with the potential to utilise the findings to guide the 13 
development of interventions to address non-adherence. Other models of behaviour 14 
change, for example the Theoretical Domains Framework (Cain et al., 2012) could 15 
also be useful but are not specifically designed to address the topic of medication 16 
adherence.  17 
Medication adherence support is particularly important early after stroke because the 18 
risk of recurrent stroke is highest at this time (Mohan et al., 2011), and because early 19 
non-commencement of or non-adherence to medications is associated with poor 20 
long-term adherence (Thrift et al., 2014; Tsai et al., 2014), yet there are no 21 
qualitative studies in the literature that focus on this time period, with people often 22 
participating many months or years post-stroke (Gibson et al., 2020). The 23 
development of self-management strategies is a priority area for stroke nursing 24 
research (Rowat et al., 2016), and could include supported self-management in 25 
6 
 
relation to medication adherence. A case study of one such intervention has 1 
suggested that strategies should include targeted education, regular review, and 2 
consideration of personal circumstances such as affordability (Kim at al., 2015). The 3 
importance of interprofessional practice and provision of support for self-4 
management from nurses and other health professionals has also been identified 5 
more generally, in relation to medication adherence for people with chronic disease 6 
in primary care (Kvarnström et al., 2018). However, only one previous study (Bauler 7 
et al., 2014) has considered the perspectives of nurses, yet their expertise and day-8 
to-day practice in medication management and administration may be valuable in 9 
identifying and addressing potential problems.  10 
 Aim 11 
The aim of this study was to utilise the Perceptions and Practicalities framework 12 
(Harding and Horne, 2001) to explore the views and experiences of stroke survivors, 13 
informal carers, and stroke unit nurses about challenges and solutions in adhering to 14 
medication early after hospital discharge following a stroke. 15 
 16 
METHODOLOGY 17 
Study design 18 
A qualitative approach was used with semi-structured individual and group 19 
interviews. A thematic approach was utilised for data collection and analysis, based 20 
on the ‘Perceptions and Practicalities’ (PaPa) model (Harding and Horne, 2001). 21 
Major themes were delineated in the interview schedule; sub-themes relating to 22 




A single stroke unit in England, UK, with acute and rehabilitation facilities at two sites 1 
within the same NHS hospital Trust, from June 2013- May 2014.. 2 
Sampling and recruitment  3 
 4 
A purposive, maximum variation sample was recruited of stroke survivors, informal 5 
carers, and registered nurses. Eligibility criteria are shown in Table 1. Nurses with a 6 
range of seniority and length of experience were recruited via email and personal 7 
contact with the participating stroke unit. We endeavoured to include stroke survivors 8 
after first or recurrent strokes, and those who lived alone or with a family member. 9 
Before discharge, stroke survivors were given information about the study by a 10 
research nurse and were asked for permission to forward their details to the 11 
researchers. A researcher telephoned the stroke survivor approximately one week 12 
after discharge to arrange a face-to-face interview, to take place within 60 days (2 13 
months) of discharge. Informal carers were recruited by asking stroke survivors to 14 
give an information leaflet to someone they wished to be present at the interview.  15 
All participants had capacity to consent to participate and all agreed to the use of 16 
anonymised direct quotes in reporting of the study findings.   17 
Data collection continued until no new themes were identified. The research team 18 
comprised researchers with clinical nursing experience and expertise in stroke 19 
research, including qualitative methods. None were working in a clinical role at the 20 
time of the study. The lead researcher (Author 1) also holds a post-registration 21 
qualification in prescribing. 22 
Data collection 23 
Semi-structured interviews were conducted by either (author 1 or author 2). 24 
Interviews with stroke survivors and informal carers were held at stroke survivors’ 25 
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homes. Individual (n=7) or small group interviews (one interview with two 1 
participants; two with three participants each) with nurses were held in a quiet room 2 
on the stroke unit. The topic guides, based on the PaPa framework (Harding and 3 
Horne, 2001) included: people’s perceptions of factors affecting medication 4 
adherence and beliefs about medications after stroke; and their lived experience of 5 
the practicalities of taking medication after stroke and of solutions and strategies to 6 
address or prevent difficulties. Brief demographic and medical data were also 7 
requested from stroke survivors, and data about professional education and 8 
experience from nurses. Overall interview duration ranged from 13-50 minutes. Data 9 
collection took place between June 2013 and May 2014. 10 
Data analysis 11 
All interviews were digitally audio-recorded and fully transcribed. Initial thematic 12 
coding was undertaken using NVivo 10 software.  The PaPa framework was used as 13 
an overarching structure. Initial codes were clustered via a process of constant 14 
comparison, which was undertaken iteratively by (Authors 1 and 2). Coding was 15 
compared and discussed where needed to reach agreement. Interpretation of 16 
interview content was verified by sharing coding with participants. 17 
 18 
RESULTS 19 
Participants’ characteristics 20 
The 27 participants included 15 nurses (of 40 eligible), all of whom were qualified to 21 
diploma (n=12) or bachelor’s degree (n=3) level. Most (10/15) were staff nurses 22 
(NHS Band 5); five were more senior. Ten worked on the acute stroke setting, four in 23 
rehabilitation, and one across both settings. They typically had 6-10 years post-24 
registration experience and at least one year’s experience in stroke nursing. Nine 25 
9 
 
stroke survivors participated (of 16 approached), of whom 6 were female and 3 were 1 
male. Their ages ranged from 52-76 years (mean 61.8 years). Three informal carers 2 
also participated at the invitation of stroke survivors. Characteristics of stroke 3 
survivors and carers are detailed in Table 2. Where verbatim quotes are provided, 4 
these have been edited where necessary to remove any potentially identifying 5 
details, and are identified only by participant number. 6 
 7 
Four major themes were identified, the fourth theme having two sub-themes. These 8 
and the codes associated with them are summarised in Figure 1. 9 
 10 
Theme 1: Perceptions of medication taking after stroke 11 
Codes included in this theme were: resisting medicines; age; personality traits; 12 
embarrassment; depression; and the preventive nature of medication - lack of 13 
obvious evidence of benefit and lack of improvement post-stroke. 14 
 15 
Nurses described a number of barriers relating to stroke survivors’ beliefs and 16 
concerns about medication. The impact of age on motivation was thought to be 17 
variable: whilst some older stroke survivors accepted the necessity for medication, 18 
others’ motivation might be affected by low mood or depression: 19 
 20 
“Their whole life’s changed and they’re really down in the dumps and they don’t want 21 
to live at all...(so they think) “What’s the point in taking tablets?”…” (RS04) (Nurse, 22 




Nurses also felt that younger people might resist the idea of taking medication 1 
because of stigma, especially if it was the only obvious reminder of their stroke: 2 
  3 
“…if they’re…with family and friends, they’ll just feel “Oh I’ll have to get all these 4 
tablets out of my handbag”…” (AS02, 03, 04) (Nurses, acute unit) 5 
 6 
Resistance to medication might also be related to personality traits:  7 
 8 
“…some people can be quite stubborn…they’ll say “Well…I’m not taking it…and 9 
that’s it.” (AS02,03,04)(Nurses, acute unit) 10 
 11 
Nurses felt that the lack of obvious benefit with secondary prevention medications 12 
contributed to poor adherence and unsupervised discontinuation. They noted that 13 
motivation and adherence might be higher with warfarin than with other drugs 14 
because the necessary regular monitoring of coagulation provided ongoing evidence 15 
of its effectiveness. For stroke survivors, evidence that medication was “vitally 16 
important” was inherent in its implicit endorsement by health professionals and the 17 
health service, “…otherwise why would you be given it?”  (RP09). 18 
 19 
Generally, stroke survivors believed that it was important to take medication, but 20 
when asked if they felt that the medication was beneficial., many of them hesitated 21 
before answering. Absence of a further stroke and of significant side effects were 22 




“I feel okay…the medication is doing what it is supposed to be doing…I know that it 1 
thins the blood and…it hopefully will prevent having another [stroke]” (AP04)  2 
 3 
One survivor of a recurrent stroke, who was prescribed 13 different medications, felt 4 
that this polypharmacy was a negation of her efforts to rehabilitate after her first 5 
stroke:  6 
 7 
“I shouldn’t have to take all them, you want to feel like you’re doing well in life, don’t 8 
you, but you’re not well…I fought through the first stroke, for my speech and 9 
movement and walking, and then I’ve had another [stroke] and I’ve been fighting 10 
through that…and then I’m taking more pills” (AP07, AC02)  11 
 12 
Similarly, nurses identified that stroke survivors might feel unmotivated to continue 13 
medications if there was little sign of physical recovery: 14 
 15 
“You have, every day, ten tablets…(but)…you don’t feel any better…your arm is still 16 
without movement…and [you think] ‘I’m taking tablets every day…there is no point in 17 
taking it’” (AS8, AS9, AS10) (Nurses, acute unit) 18 
 19 
Theme 2: Perceptions about those at higher risk of poor medication adherence 20 
Codes included in this theme were: living alone; no/limited carer support; stroke 21 
severity - post stroke disability/practical issues; motivational issues; and ‘hidden’ 22 
problems. This theme included both social and clinical characteristics. Nurses were 23 
aware of many possible predictors of adherence problems, but their identification of 24 




Nurses felt that living alone was a risk factor for poor adherence, and indeed, all 2 
stroke survivors in the study, irrespective of their living arrangements, received 3 
informal support to obtain, organise or remember to take medication. This practical 4 
assistance was also a tangible expression of the informal carer’s emotional support 5 
and concern:  6 
 7 
“… I’ll tell him [husband] - you don’t need to remind me, I know what I’m doing…but I 8 
think it’s a shock for them as well …just for that first...two or three weeks…he’s 9 
probably thinking it’s better to remind me to make sure…” (AP04)  10 
 11 
Nurses felt that stroke severity impacted on adherence in various ways. Physical or 12 
cognitive problems might directly cause practical difficulties and could also lead to 13 
incorrect assumptions about the futility of preventive measures. Conversely, in 14 
people who had recovered fully, denial and lack of understanding of the potential 15 
seriousness of the stroke might also lead to poor adherence.  16 
 17 
Nurses felt that past problems with medication adherence, or numerous queries from 18 
a stroke survivor about their medication while in hospital., suggested a lack of 19 
understanding or confidence and might predict poor post-discharge adherence. 20 
Nurses would also suspect poor prior adherence in stroke survivors who expressed 21 
reluctance to take medication, or where there was direct evidence: 22 
 23 
 “Sometimes they come in with tablets that are out of date, you know they’ve had 24 




Although stroke survivors and informal carers were not directly asked about how 2 
people’s risk of poor medication adherence might be identified, some who initially 3 
stated that they had not had any adherence problems then acknowledged such 4 
difficulties later in the interview. This suggests that current and potential medication 5 
adherence problems might easily be overlooked by health professionals:  6 
 7 
“It’s not been a problem really at all.” (AP01) - later described forgetting to take 8 
medication, difficulties with splitting tablets into quarters and with swallowing. 9 
 10 
“No problems with them…none at all, and I don’t think there’s any side effects.” 11 
(RP09) - later described difficulties with manual dexterity, opening packets and 12 
dropping tablets. 13 
 14 
Theme 3: Practicalities of taking medication early after stroke 15 
Codes included in this theme were: mobility; co-ordination; manual dexterity; 16 
swallowing; vision; aphasia (verbal and written communication); cognitive impairment; 17 
and system issues (short length of stay; workload) 18 
People with limited mobility experienced difficulties in obtaining their prescriptions 19 
and supplies of medication, and also had to identify a secure but accessible place to 20 
store medications at home. Post-stroke problems with co-ordination and dexterity 21 
were also a barrier: 22 
 23 
“…the (medication) packets are a pain in the neck…I’m one-handed initially, so I 24 




“If…nobody thought to put them (medications) within reach, then he wouldn’t be able 2 
to get them.” (RS02 Nurse, rehabilitation unit)  3 
 4 
Post-stroke dysphagia was mentioned by all nurses as a potential barrier. None of 5 
the stroke survivors had persistent dysphagia, but those who had transient problems 6 
early after their stroke still had a fear of tablets getting ‘stuck’. 7 
 8 
Some stroke survivors reported difficulties in reading medication labels, and nurses 9 
recognised that visual impairments were a potential barrier: 10 
  11 
“… you’ve got to make sure they can read (the labels) …before they get home… you 12 
could have a hemianopia” (AS11) (Nurse, acute unit) 13 
 14 
Nurses suggested that aphasia could be a barrier to medication adherence, making 15 
it challenging for health professionals or other carers to assess understanding, and 16 
for stroke survivors to communicate difficulties or queries: 17 
 18 
“… they might say no [to medication] and they mean yes…” (RS02) (Nurse, 19 
rehabilitation unit) 20 
 21 
Other barriers suggested by nurses included post-stroke cognitive impairment, 22 
especially when combined with polypharmacy; likewise, stroke survivors, none of 23 
whom had significant cognitive impairment, also described difficulties with 24 




“There was a great big bag with all the boxes in…and one of the boxes we missed…I 2 
don’t remember them saying you’re on two lots of tablets…”(AP01)  3 
 4 
Organisational barriers to adherence included poor communication at admission and 5 
discharge, short lengths of hospital stay, and lack of availability of nurses to discuss 6 
medications. Pressure on bed availability could lead to rushed discharges and 7 
communication failures:  8 
 9 
“We’re supposed to sit with the patient and go through the discharge 10 
summary…(but) new admissions are here even before the old patient has left the 11 
ward” (AS07) (Nurse, acute unit). 12 
 13 
Similarly, stroke survivors’ reports of information provision were variable:  14 
 15 
“…on the day I was going [home], she [nurse] gave me full details about the 16 
medication…we had a question and answer session about my understanding…” 17 
(AP03)  18 
 19 
 “[nurse] said “take these”…it could have been anything…perhaps they could have 20 
told me…what they [tablets] were actually going to do” (AP01)  21 
 22 
Theme 4 23 
This theme addressed the practicalities of addressing medication adherence after 24 
stroke, in the light of insights from themes 1-3. During analysis, it became clear that 25 
16 
 
the overall theme fell into two areas: a) pre-emptive measures that could be 1 
implemented during the hospital stay, and b) measures that could be used after 2 
discharge to address emergent and ongoing medication adherence issues. We thus 3 
created two subthemes. 4 
Theme 4a: Practicalities of addressing poor medication adherence during the 5 
hospital stay 6 
Codes included in this theme included: a consistent approach to identifying 7 
adherence issues; medication rounds for problem identification and teaching; 8 
assessment and planning of individual support, carer involvement; face to face 9 
discussion (patient, carer, nurse, pharmacist, doctor); multidisciplinary team 10 
approaches; and having a ‘co-ordinator of pills’.  11 
 12 
Solutions suggested by nurses to improve stroke survivors’ medication adherence 13 
included incorporating education in medication rounds, regime simplification, 14 
individual assessment and planning, carer involvement, and multidisciplinary 15 
communication: 16 
 17 
 “We could do with a multidisciplinary team meeting with a nurse, patient and a 18 
relative and the pharmacist…it has to be on an individual basis ’cos everyone’s 19 
different” (AS05,06) (Nurses, acute unit) 20 
 21 
In practice, however, pre-discharge support was uncoordinated and often rushed or 22 
even omitted due to time pressures:  23 
“Every patient that’s discharged we go through them [the medication] – well, I do, I 24 




“…we go through it [discharge summary] with the main carer…but we don’t always 2 
have time to go through everything properly” (RS01) (Nurse, rehabilitation unit) 3 
 4 
Likewise, a stroke survivor highlighted the need for a ‘co-ordinator of pills’:  5 
 6 
“just invent one person that can put it all together…I just wish there was 7 
somebody…what do you call ’em, co-ordinator of pills [laugh]” (AP07, AC02)  8 
 9 
Theme 4b: Practicalities of addressing medication adherence issues after 10 
discharge 11 
Codes included in this theme were: evolving a system; extra support in the first few 12 
days and weeks, practical organisation methods; schedules, reminders, phone 13 
alarms; safe storage and administration; carer support (practical help, prompting, 14 
‘surveillance’, reciprocity); GP follow up and medication adherence checks; and 15 
telephone follow-up contact with stroke unit nurse. 16 
 17 
Stroke survivors and informal carers developed diverse solutions and adaptations to 18 
address medication adherence difficulties after returning home, including purpose-19 
made or improvised pill organisers, schedules, electronic, written or personal 20 
reminders, and strategies to ensure safe administration and storage: 21 
  22 
“I’m one-handed, trying to get it out and not have the tablet go at ninety miles an 23 
hour…across the floor, and I’m worrying about my dog…(I have to make sure) the 24 




Informal carers often provided active prompting. This was seen as ‘automatic’ 2 
(AP06) but was not always wholly welcomed:  3 
 4 
“At the beginning he said “have you taken (your medication)?”… just checking 5 
up…and he won’t stop doing it…he goes over the top a bit” (AP04)  6 
 7 
Provision of weekly prepacked blister packs also facilitated discreet surveillance and 8 
support from the carer:   9 
 10 
“I just presumed she were getting on with it and she kept forgetting them…now I can 11 
glance down (at the blister pack)… and know that she’s took the morning ones…it 12 
just makes my life easier” (AP07, AC02)  13 
 14 
In some cases, this support was reciprocated by the stroke survivor: 15 
  16 
 “I [carer] take medication, and I forget mine if I’m not careful and [name] reminds 17 
me, so we look after each other” (AP05, AC01)  18 
 19 
“(after dinner my husband) says ‘What are you taking?’ and I’ll say ‘I’m taking a 20 
statin,’ [laughs] and he says ‘I’m taking my statin now too…is this a pudding?” 21 
[laughs]” (AP04).  22 
 23 
Informal carers also provided practical support to obtain repeat prescriptions or to 24 




“It's not been a hassle for me (blood tests) because…my sister-in-law took me to 2 
hospital… because you just can’t walk that [far]” (AP08, AC03).  3 
 4 
Nurses suggested that telephone support after discharge, initiated by either party, 5 
might be helpful: 6 
 7 
 “In a couple of weeks, just ring the patient up and say…“any problems with your 8 
medicines, are you taking them?” (AS05,06) (Nurses, acute unit) 9 
“Give them a telephone number if they’re worried (about medications), tell them - 10 
“Please contact us, we’re here twenty-four hours (a day)”” (RS04) (Nurse, 11 
rehabilitation unit). 12 
 13 
General practitioners (GPs) were also cited as a potential source of post-discharge 14 
medication support, but several participants reported poor communication, 15 
exacerbated by time pressures: 16 
 17 
“The doctor sent me a letter for a review of my medication…and all she did were put 18 
it up on the computer, looked at it and said ‘Right, we don’t have to change 19 
anything,’…I really think they’re missing a few things because…they’ve only twenty 20 






This study is the first to highlight the complex challenges faced by stroke survivors 1 
and informal carers in evolving a system to manage medication early after discharge. 2 
It is also the first study to focus on the contributions of stroke unit nurses to 3 
addressing these challenges. Stroke unit nurses’, stroke survivors’ and carers’ 4 
perceptions of medication adherence echo the issues of lack of support, 5 
polypharmacy (Al Al-Shaikh, 2016a), and the need for trust in medicines (Gibson et 6 
al., 2020), and this trust is also implicit in stroke survivors’ acceptance of the 7 
endorsement of medicines by health professionals.  8 
Nurses’, stroke survivors’ and carers’ views were mostly reflective of each other, 9 
notably in relation to the lack of obvious benefit of secondary prevention, the impact 10 
of physical stroke sequelae such as manual dexterity and dysphagia, the importance 11 
of carer support, and organisational factors. Delivery of education and support by 12 
nurses about post-stroke medication was recognised as important, but both nurses’ 13 
and stroke survivors’ experiences of this were variable. 14 
Our study highlights that the challenges faced by stroke survivors on returning home 15 
stem from the need for rapid transition, from being passive recipients of medication, 16 
to self-management of often complex medication regimes, and the multiple activities 17 
relating to this medicines work. These include initiating medication reviews, 18 
organising and undergoing necessary monitoring, organising and obtaining repeat 19 
prescriptions, storing medications safely, taking medications on schedule, and 20 
resolving any problems. Far from the ideal of supported self-management (Rowat et 21 
al., 2016), this rapid, largely unsupported transition adds significantly to the 22 
treatment burden (Gallacher et al., 2019) shouldered by stroke survivors and 23 
informal carers in the first weeks after discharge, when the underlying risk of 24 
recurrent stroke is highest and the need to establish a consistent and manageable 25 
21 
 
medication regime is greatest. In this study, nurses also appeared to recognise many 1 
of the potential problems that stroke survivors also identified and that have been 2 
reported in other studies (Al AlShaikh et al., 2016a), such as polypharmacy and the 3 
lack of support, and described how they attempted to resolve them via opportunistic 4 
assessment and individualised support. However, if this area of nursing knowledge 5 
and practice is not recognised formally in the work of the stroke unit, nurses are 6 
unable to provide the comprehensive advice and support needed.  7 
 8 
This qualitative study adds to our understanding of the challenges faced by stroke 9 
survivors, carers and nurses around medication adherence early after stroke, and 10 
suggests some possible solutions which are worthy of further investigation. By using 11 
the PaPa framework (Harding and Horne, 2001) the findings capture practical 12 
problems and complex strategies, and portray how people develop solutions by trial 13 
and error in the early days at home after a stroke. Although previous qualitative 14 
studies (Bauler et al., 2014; Souter et al., 2014; Jamison et al., 2016) have 15 
highlighted the contributions of various professional groups in post-stroke medication 16 
adherence, this study is the first to focus on the contribution of nurses working in 17 
inpatient stroke settings, synthesising their perspectives with those of stroke 18 
survivors and informal carers to formulate a shared understanding which may 19 
contribute to the development of collaborative, multidisciplinary solutions.  20 
The study has a number of limitations. It was a small single centre study conducted 21 
with stroke survivors, informal carers and nurses from only one stroke unit. Thus, 22 
although we were able to develop the key themes of the PaPa framework in some 23 
depth in relation to post-stroke medication taking, exploration of other professionals’ 24 
experiences and views, notably those of community nurses and other members of 25 
22 
 
the stroke multidisciplinary team, might have led to the development of further sub-1 
themes. Caution should be exercised in generalising the findings to other settings 2 
and in considering transferability of the recommendations. Notably, no participants 3 
mentioned the cost of medicines, perhaps because prescription medications in the 4 
UK National Health Service are provided free or for a small flat-rate payment, but in 5 
some other health care systems, medication costs may have more impact on 6 
adherence (Lummis et al., 2008). We found during recruitment that stroke survivors 7 
who did not acknowledge having difficulties with their medication were perhaps less 8 
interested in participating, so the study may over-represent the views of those who 9 
did experience problems. The problems disclosed by stroke survivors related almost 10 
entirely to unintentional non-adherence, and few inferences can be made about 11 
intentional non-adherence. Although the study protocol allowed for the recruitment of 12 
people with cognitive or communication disabilities after stroke in light of the 13 
potential impact of these on adherence, we were not successful in recruiting any 14 
such participants. Only a small number of informal carers agreed to participate, and 15 
none of them supported a stroke survivor who was wholly reliant on them for 16 
medication taking. Exploration of the perspectives of community nurses who support 17 
stroke survivors would have also been valuable to enable an understanding of how 18 
nurses contribute to post-stroke medication management on both sides of the 19 
discharge process. This is particularly pertinent given the recent development of 20 
‘early supported discharge’ approaches, in which nurses play key roles in dedicated 21 
multidisciplinary community stroke teams. 22 
Although the findings of this small, single centre study should be interpreted with 23 
caution, they suggest several areas for further research. Multidisciplinary team 24 
approaches to post-stroke medication adherence need to be developed and tested, 25 
23 
 
spanning both inpatient and community settings. These should focus on education, 1 
training and support for both stroke survivors and carers where appropriate. The 2 
views and experiences of carers, especially those who support a person with severe 3 
post-stroke disability, and of nurses working in community settings, are also under-4 
researched.  5 
 6 
CONCLUSION  7 
This study has highlighted stroke survivors’, carers’ and stroke nurses’ perceptions 8 
of taking medication early after discharge, perceptions about those at risk of poor 9 
medication adherence, the practicalities of managing medication at this time, and the 10 
practicalities of identifying and addressing potential and emerging problems. 11 
Perceptions of post-stroke medication are influenced by the lack of obvious benefit 12 
derived from secondary prevention medication, in the context of ongoing stroke 13 
disability and other factors such as age and embarrassment. Those living alone, with 14 
limited support, and with specific post-stroke disabilities, including hidden disabilities, 15 
or with low motivation, are perceived to be most at risk. After discharge, stroke 16 
survivors and carers have to address the practicalities of managing medications, 17 
often with little or no preparation. Practical methods to proactively address poor 18 
medication adherence during the hospital stay need to use a consistent, 19 
multidisciplinary and co-ordinated approach, with comprehensive individualised 20 
assessment and support. Practical methods utilised by stroke survivors and carers 21 
after discharge centre on ‘evolving a system’, including scheduling, safe storage, and 22 
carer support. Follow-up support by the stroke unit and from primary care are also 23 
important but inconsistently delivered.  24 
24 
 
Stroke survivors are at risk of avoidable medication adherence problems early after 1 
discharge. This reduces the efficacy and safety of their prescribed medications and 2 
contributes to stroke recurrence in both the short and longer term. Systematic 3 
multidisciplinary systems of support, within which nurses contribute to identifying 4 
potential problems and supporting medication adherence, might facilitate adherence 5 
early after discharge. The contributions of informal carers may be vital to ensuring 6 
medication adherence after stroke and should also be integrated into the stroke 7 
survivor’s care plan where appropriate. 8 
 9 
Key points: 10 
 11 
• Numerous practical and motivational problems affect medication adherence 12 
early after stroke 13 
• Stroke survivors have to evolve a system largely unaided to manage their 14 
medications effectively.  15 
• The expertise of stroke unit nurses in this area is not well-used. 16 
• Multidisciplinary strategies to support stroke survivors with medication 17 
adherence early after discharge need to be developed and evaluated. 18 
 19 
 20 
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securely held in electronic form on a secure password-protected server at the host 2 
academic institution. The COREQ guidelines were consulted in reporting of the 3 
study. 4 
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Table 1: Eligibility criteria for participation 
Stroke survivors  
First or recurrent stroke as primary diagnosis leading to hospital admission 
Aged 18 or over 
Discharged to own home (not residential care) 
Not receiving end-of-life care 
Prescribed new and/or continuing oral medication on discharge 
Able to converse in English 
Having capacity to consent to participation 
Informal carers 
Aged 18 or over 
Friend or relative providing practical and/or emotional support for a participating 
stroke survivor 
Able to converse in English 
Nurses 
Registered nurses (all aged 18 or over and able to converse in English). 
Working on acute and/or rehabilitation stroke unit 
Nurses in full – or part-time posts 
 2 






























(N = additions + 
discontinuations) 
AP01 54 F Spouse Alone First 4 17 9 11 2 
AP02 75 M Alone Alone First 4 27 8 10 2 
AP03 52 M Spouse Alone First 1 60 0 2 2 
AP04 65 F Spouse Alone First 2 40 0 2 2 
AP05 76 F Spouse Spouse First 2 51 4 6 4 
AP06 52 F Spouse Alone First 1 50 4 4 4 
AP07 53 F Spouse Spouse Recurrent 19 52 13 13 0 
AP08 72 F Alone Sister in 
law 
Recurrent 2 43 4 5 1 
RP09 60 M Alone Alone First 31 57 1 3 2 
 4 
 5 
Figure 1: Themes identified in interviews with nurses, stroke survivors and informal 6 
carers about medication adherence early after stroke. 7 
 8 
 9 
 10 
 11 
 12 
